Please be aware that Mahajan Imaging & Labs will never request for your bank details or OTP for booking/registration purposes.

What is a MYOSITIS PROFILE EXTENDED IgG : 16 ANTIGENS?

The **Myositis Profile Extended IgG: 16 Antigens test** is a specialized blood test that detects autoantibodies associated with **idiopathic inflammatory myopathies (IIMs)** such as polymyositis, dermatomyositis, and overlap syndromes. By analyzing IgG antibodies against 16 specific antigens, this test helps identify autoimmune muscle inflammation and related systemic involvement. Healthcare professionals recommend it for patients with unexplained muscle weakness, joint pain, or suspected autoimmune disorders. It aids in accurate diagnosis, prognosis, and guiding treatment strategies for complex myositis conditions.

Additional Information

Also known as/ Other names: Extended Myositis Antibody Panel, Myositis Specific Antibody Profile (16 Antigens), Comprehensive Myositis IgG Panel, Extended Inflammatory Myopathy Antibody Panel
Parameters: 16
Recommended for: M/F/Others
Sample Type: Blood
Patient Preparation: No prior preparation is needed
Reports: 2 days

FAQs

Why is this test important?

It provides specific antibody information that aids in diagnosing, classifying, and managing autoimmune muscle inflammation and related systemic conditions.

Who should undergo this test?

Patients with unexplained muscle weakness, joint pain, skin rashes, or suspected autoimmune myopathy are often recommended this test.

What does a positive antibody result mean?

It suggests the presence of autoimmune myopathy or overlap syndromes, requiring clinical correlation and further evaluation.

Can the test be negative in myositis patients?

Yes, some patients may test negative, so results must be interpreted alongside clinical findings and other investigations.

Is the test specific for myositis?

Yes, the antibodies detected are strongly associated with idiopathic inflammatory myopathies and related autoimmune conditions.

Can medications affect the test results?

Yes, immunosuppressive drugs may lower antibody levels, influencing test outcomes.

Is the test used for monitoring treatment?

It is mainly diagnostic but repeat testing may help track antibody persistence or disease progression.

Text copied to clipboard
Dynamic badges will be added here